Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2023 June;114(3) > Minerva Medica 2023 June;114(3):357-71

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Medica 2023 June;114(3):357-71

DOI: 10.23736/S0026-4806.22.07879-X

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review

Maria S. VALLE 1, Cristina RUSSO 2, Antonino CASABONA 1, Nunzio CRIMI 3, Claudia CRIMI 4, Valeria COLAIANNI 2, Matteo CIONI 1, 5, Lucia MALAGUARNERA 2

1 School of Medicine, Department of Biomedical and Biotechnological Sciences, Laboratory of Neuro-Biomechanics, University of Catania, Catania, Italy; 2 Section of Pathology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy; 3 Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; 4 Unit of Respiratory Medicine, Vittorio Emanuele-San Marco Polyclinic, Catania, Italy; 5 Gait and Posture Analysis Laboratory, Vittorio Emanuele-San Marco Polyclinic, Catania, Italy



Vitamin D deficiency is involved in the etiology of a broad range of diseases. Recently, some studies have shown a link between vitamin D and susceptibility to the onset of chronic obstructive pulmonary disease (COPD). COPD is characterized by chronic inflammation and irreversible airway obstruction. Systemic inflammation in COPD patients is associated with a decline in lung function. In addition, inflammation causes various extra-pulmonary symptoms, including muscle deterioration that leads to reduced strength and fatigue endurance, especially in muscles of the lower limb. In COPD the pathophysiological changes related to the inflammatory state affect oxidant-antioxidant balance, which is one of the main mechanisms promoting the progression of this disease and exacerbations. Vitamin D exerts beneficial effects and exhibits anti-inflammatory actions. Vitamin D deficiency in COPD patients affects inflammation, oxidative stress and mitochondrial impairment and can generate the development of skeletal atrophy. This systematic review offers a better understanding of the molecular mechanisms linking vitamin D deficiency to COPD and muscle weakness, and aims to establish whether vitamin D supplementation could be useful to mitigate inflammation in COPD patients.


KEY WORDS: Inflammation; Oxidative stress; Vitamin D; Pulmonary disease, chronic obstructive; Muscle weakness

top of page